Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centelion SAS
Original Assignee
Centelion SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9510825Aexternal-prioritypatent/FR2738842B1/en
Application filed by Centelion SASfiledCriticalCentelion SAS
Publication of AU6992496ApublicationCriticalpatent/AU6992496A/en
Application grantedgrantedCritical
Publication of AU728231B2publicationCriticalpatent/AU728231B2/en
Publication of AU728231CpublicationCriticalpatent/AU728231C/en
Assigned to AVENTIS PHARMA S.A.reassignmentAVENTIS PHARMA S.A.Request to Amend Deed and RegisterAssignors: RHONE-POULENC RORER S.A.
Assigned to GENCELL S.A.reassignmentGENCELL S.A.Alteration of Name(s) in Register under S187Assignors: AVENTIS PHARMA S.A.
Assigned to CENTELION S.A.S.reassignmentCENTELION S.A.S.Request to Amend Deed and RegisterAssignors: GENCELL S.A.
AU69924/96A1995-09-151996-09-13Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy
CeasedAU728231C
(en)